Skip to content

Comparison of the effect of rupivacaine - Dexedodomidineon reduction of acute pain after cesarean section

Comparison of the effect of rupivacaine - Dexedodomidine and rupivacaine - fentanyl on reduction of acute pain after cesarean section by epidural

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20191026045246N1
Enrollment
80
Registered
2020-02-27
Start date
2020-02-07
Completion date
Unknown
Last updated
2020-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cesarean section. Acute pain, not elsewhere classified

Interventions

Intervention 1: Intervention group: rupivacaine - Dexedodomidine. Intervention 2: Intervention group: rupivacaine - fentanyl.

Sponsors

Ahvaz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 30 Years

Inclusion criteria

Inclusion criteria: Elective Cesarean section with Class I and II ASA

Exclusion criteria

Exclusion criteria: Preterm labor (less than 37 weeks) asthma cardiovascular disease preeclampsia history of seizures, becoming spinal anesthesia to complete anesthesia history of chronic pain such as low back pain and fibromyalgia, opioid use mood and Psychological disorders

Design outcomes

Primary

MeasureTime frame
Pain. Timepoint: 2, 4, 8, 12 and 24 hours after surgery. Method of measurement: Visual Analog Scale.

Secondary

MeasureTime frame
The patient's first time complaining of pain. Timepoint: The first time a patient feels pain after surgery. Method of measurement: Minutes.;The amount of analgesic drug. Timepoint: The onset of pain. Method of measurement: Mg / kg.;Rupivacaine. Timepoint: Before surgery. Method of measurement: Mg / kg.;Dexedodomidine. Timepoint: Before surgery. Method of measurement: Mg / kg.;Fentanyl. Timepoint: Before surgery. Method of measurement: Mg / kg.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactReza Akhondzadeh

Ahvaz University of Medical Sciences

rezaakh@hotmail.com+98 61 3373 8414

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026